Methods for treating restenosis using annexin a5
AssigneeAnnexin Pharmaceuticals AB
InventorsKnut PETTERSSON, Johan Frostegård, Ola CAMBER
Life of this patent
Estimating the term…
Loading patent…
AssigneeAnnexin Pharmaceuticals AB
InventorsKnut PETTERSSON, Johan Frostegård, Ola CAMBER
Estimating the term…
A method for the prophylaxis or treatment of restenosis comprising administering a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof to a patient in need of such treatment. A method for the treatment of stenosis in a patient comprising performing an intervention for the treatment of stenosis in conjunction with administering a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof. A pharmaceutical composition comprising a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof for the prophylaxis or treatment of restenosis. A drug eluting stent, wherein the drug is Annexin A5 or a functional analogue or variant thereof, and a method of making such a stent.
1-19. (canceled)
A method for the treatment of restenosis, wherein the restenosis is caused by neointima formation or neointimal thickening, in a patient with restenosis, wherein the method comprises:
Dependencies are inferred from the claim text.